G J Becker

Summary

Affiliation: Royal Melbourne Hospital
Country: Australia

Publications

  1. ncbi request reprint Pharmacological intervention in renal fibrosis and vascular sclerosis
    G J Becker
    Department of Nephrology, The Royal Melbourne Hospital, Vic, Australia
    J Nephrol 14:332-9. 2001
  2. ncbi request reprint The CARI guidelines. Kidney stones: uric acid stones
    Gavin Becker
    Department of Nephrology, Royal Melbourne Hospital, Victoria, Australia, 3050
    Nephrology (Carlton) 12:S21-5. 2007
  3. pmc Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study
    Lawrence P McMahon
    Monash University, Melbourne, Australia
    BMC Nephrol 13:40. 2012
  4. pmc Asian leadership in chronic kidney disease
    Gavin J Becker
    Department of Nephrology, The Royal Melbourne Hospital, Victoria, Australia
    J Korean Med Sci 24:S3-6. 2009
  5. ncbi request reprint The CARI guidelines. Kidney stones: cystine stones
    Gavin Becker
    Department of Nephrology, Royal Melbourne Hospital, Parkville VIC 3050, Australia
    Nephrology (Carlton) 12:S4-10. 2007
  6. ncbi request reprint Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis
    T D Hewitson
    Department of Nephrology, The Royal Melbourne Hospital, Australia
    J Nephrol 14:453-60. 2001
  7. ncbi request reprint Thrombin is a pro-fibrotic factor for rat renal fibroblasts in vitro
    T D Hewitson
    Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Australia
    Nephron Exp Nephrol 101:e42-9. 2005
  8. ncbi request reprint Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function
    J M Forbes
    Victorian Paediatric Renal Service, Department of Nephrology, Royal Children's Hospital, Parkville, Victoria, Australia
    Kidney Int 59:1333-41. 2001
  9. ncbi request reprint The role of tubulointerstitial injury in chronic renal failure
    G J Becker
    Department of Nephrology, The Royal Melbourne Hospital, Parkville, Victoria, Australia
    Curr Opin Nephrol Hypertens 9:133-8. 2000
  10. ncbi request reprint Hyaluronan and rat renal fibroblasts: in vitro studies
    E Pedagogos
    Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Australia
    Nephron 88:347-53. 2001

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Pharmacological intervention in renal fibrosis and vascular sclerosis
    G J Becker
    Department of Nephrology, The Royal Melbourne Hospital, Vic, Australia
    J Nephrol 14:332-9. 2001
    ....
  2. ncbi request reprint The CARI guidelines. Kidney stones: uric acid stones
    Gavin Becker
    Department of Nephrology, Royal Melbourne Hospital, Victoria, Australia, 3050
    Nephrology (Carlton) 12:S21-5. 2007
  3. pmc Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study
    Lawrence P McMahon
    Monash University, Melbourne, Australia
    BMC Nephrol 13:40. 2012
    ..Nonetheless, a causative role has not been demonstrated, and this potential relationship requires further appraisal in such a complex patient group...
  4. pmc Asian leadership in chronic kidney disease
    Gavin J Becker
    Department of Nephrology, The Royal Melbourne Hospital, Victoria, Australia
    J Korean Med Sci 24:S3-6. 2009
    ..With a rapidly developing scientific community, Asia needs to accept the challenge of becoming a global leader in nephrology in the near future...
  5. ncbi request reprint The CARI guidelines. Kidney stones: cystine stones
    Gavin Becker
    Department of Nephrology, Royal Melbourne Hospital, Parkville VIC 3050, Australia
    Nephrology (Carlton) 12:S4-10. 2007
  6. ncbi request reprint Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis
    T D Hewitson
    Department of Nephrology, The Royal Melbourne Hospital, Australia
    J Nephrol 14:453-60. 2001
    ..The objective of this study was therefore to determine if these effects include down-regulation of fibroblast function...
  7. ncbi request reprint Thrombin is a pro-fibrotic factor for rat renal fibroblasts in vitro
    T D Hewitson
    Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Australia
    Nephron Exp Nephrol 101:e42-9. 2005
    ..This study examines whether thrombin may potentially exacerbate fibrosis by upregulating the function of interstitial fibroblasts in vitro...
  8. ncbi request reprint Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function
    J M Forbes
    Victorian Paediatric Renal Service, Department of Nephrology, Royal Children's Hospital, Parkville, Victoria, Australia
    Kidney Int 59:1333-41. 2001
    ..Blockade of both ETA and ETB receptors, however, appears to be detrimental to long-term kidney function...
  9. ncbi request reprint The role of tubulointerstitial injury in chronic renal failure
    G J Becker
    Department of Nephrology, The Royal Melbourne Hospital, Parkville, Victoria, Australia
    Curr Opin Nephrol Hypertens 9:133-8. 2000
    ..The behaviour and control of the renal fibroblast is being investigated, with the potential for direct interference with its functions...
  10. ncbi request reprint Hyaluronan and rat renal fibroblasts: in vitro studies
    E Pedagogos
    Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Australia
    Nephron 88:347-53. 2001
    ..Furthermore, the findings in this study suggest that HA may be an important mediator in reducing renal cortical fibroblast collagen production and may play an important role in limiting renal interstitial scarring...
  11. ncbi request reprint Treatment of renovascular disease with percutaneous stent insertion: long-term outcomes
    V Perkovic
    Department of Nephrology, Royal Melbourne Hospital, Melbourne, Australia
    Australas Radiol 45:438-43. 2001
    ..Restenosis was common after 6 months, occurring eventually in 29% of screened patients, but was not shown to affect clinical outcomes. Insertion of renal artery stents is a safe and effective treatment for renal artery stenosis...
  12. ncbi request reprint Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure
    J M Forbes
    Victorian Paediatric Renal Service, Royal Children's Hospital, Parkville, Vic, Australia
    Exp Nephrol 9:309-16. 2001
    ....
  13. ncbi request reprint Intracellular cyclic nucleotide analogues inhibit in vitro mitogenesis and activation of fibroblasts derived from obstructed rat kidneys
    T D Hewitson
    Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Vic, Australia
    Nephron Exp Nephrol 96:e59-66. 2004
    ..Strategies which elevate intracellular cyclic nucleotide concentrations may therefore be therapeutically valuable in preventing the proliferation and activation of fibroblasts in progressive renal disease...
  14. ncbi request reprint Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro
    Rosemary Masterson
    Department of Nephrology, Royal Melbourne Hospital, and Department of Medicine, University of Melbourne, Victoria, Australia
    Nephrol Dial Transplant 19:544-52. 2004
    ..This study was conducted to further elucidate the antifibrotic mechanisms of relaxin on renal fibroblasts in vitro...
  15. ncbi request reprint Impact of statin treatment on 1-year functional and histologic renal allograft outcome
    Rosemary Masterson
    Department of Nephrology, Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia
    Transplantation 80:332-8. 2005
    ..A retrospective study was undertaken to establish the impact of statins on graft outcome in the first year posttransplantation...
  16. ncbi request reprint Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro
    Rosemary Masterson
    Department of Nephrology, Royal Melbourne Hospital, Melbourne, Australia
    Nephron Exp Nephrol 102:e19-29. 2006
    ..We studied the effects of a farnesyltransferase inhibitor BMS-191563 and geranylgeranyltransferase inhibitor GGTI-298 on renal fibrogenesis in vitro...